Comparison of patients in the BRAF- and NRAS-mutated arms with TCGA melanoma cases showed overall concordance of the tumor genetic landscape with regard to the percentage of patients experiencing alterations in the most frequently mutated genes (Supplementary Figure 1A and 1B). The gene discussed is BRAF; the disease is melanoma.